Analyses / Public Summary / 119 · SJRES 141 Public Summary

119-SJRES-141 Journalist Public Summary

119 · SJRES 141 A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by Bureau of Consumer Financial Protection relating to the withdrawal of the rule relating to "Debt Collection Practices (Regulation F); Deceptive and Unfair Collection of Medical Debt".

A Senate resolution would overturn the CFPB’s 2025 move that withdrew its 2024 guidance warning against deceptive or unfair medical‑debt collection, aiming to restore those consumer protections. (govinfo.gov)

Published
28 Apr 2026
Updated
28 Apr 2026
Tags
Public Summary · Congressional Review Act · Medical Debt
Unvetted
01 · Section

Headline Summary

A short bill to undo a recent CFPB step: it would nullify the Bureau’s 2025 withdrawal of its 2024 medical‑debt collection guidance, effectively reviving that consumer‑protection policy. (govinfo.gov)

02 · Section

What It Does

This is a Congressional Review Act (CRA) resolution that targets a specific CFPB action. In May 2025, the CFPB published a rule withdrawing 67 guidance documents—including an October 2024 advisory opinion reminding debt collectors that deceptive or unfair practices when collecting medical bills violate the Fair Debt Collection Practices Act and Regulation F. The resolution would disapprove that withdrawal; under the CRA, a disapproved rule has “no force or effect.” (govinfo.gov)

03 · Section

Why It Matters

If successful, the measure would restore a federal backstop against practices like trying to collect medical bills that were already paid or not actually owed, and against misrepresenting how medical debt affects a person’s credit—issues the CFPB highlighted in its 2024 advisory opinion and press statement. Supporters say this helps patients avoid surprise collections and credit harm tied to billing errors. (consumerfinance.gov)

04 · Section

Who’s For It

  • Sen. Raphael Warnock (sponsor) and several Senate Democrats who have pressed the CFPB to curb harmful medical‑debt practices; they argue the 2024 guidance protected patients from illegal collections. (govinfo.gov)
  • Consumer advocates (e.g., National Consumer Law Center) who opposed the CFPB’s withdrawal and say the guidance clarified existing law and reduced abusive tactics. (library.nclc.org)
05 · Section

Who’s Against It

  • Current CFPB leadership under the 2025 notice, which withdrew the guidance while emphasizing a shift away from sub‑regulatory guidance toward formal rules; they argued withdrawals would reduce confusion and unnecessary burdens. (govinfo.gov)
  • Financial industry and credit‑union groups that welcomed the withdrawal and prefer policy to run through notice‑and‑comment rulemaking rather than guidance. (americascreditunions.org)
06 · Section

What’s Next

Status as of April 27, 2026: Introduced in the Senate on March 19, 2026; the Banking Committee was discharged by petition under CRA procedures, and the measure was placed on the Senate Legislative Calendar (General Orders). Next steps are a Senate floor vote, then House consideration; if both chambers pass it, it goes to the President. Under the CRA, enactment would make the CFPB’s 2025 withdrawal “of no force or effect.” (govinfo.gov)

Discussion